Fan Dong - Jafron Biomedical GM Directors
| 300529 Stock | 30.48 0.41 1.36% |
Director
Fan Dong is GM Directors of Jafron Biomedical Co
| Age | 54 |
| Address | No. 98 Technology Six Road, Zhuhai, China, 519085 |
| Phone | 86 75 6368 9708 |
| Web | https://www.jafroninternational.com |
Jafron Biomedical Management Efficiency
The company has return on total asset (ROA) of 0.1052 % which means that it generated a profit of $0.1052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2476 %, meaning that it generated $0.2476 on every $100 dollars invested by stockholders. Jafron Biomedical's management efficiency ratios could be used to measure how well Jafron Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jafron Biomedical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 272.2 M, whereas Intangible Assets are forecasted to decline to about 53.5 M.Similar Executives
| Found 11 records | DIRECTOR Age | ||
| Jingli Ma | Shenyang Huitian Thermal | 47 | |
| Xuanyu Jin | Hubei Geoway Investment | 35 | |
| Yi Jiang | Nanjing Putian Telecommunicatio | 44 | |
| Bin Yang | Tianjin Realty Development | 57 | |
| Xigang Sun | Nanjing Putian Telecommunicatio | 52 | |
| Jinzi He | Shenzhen Hifuture Electric | 39 | |
| Pengye Xu | Shenyang Huitian Thermal | 48 | |
| Junshan Li | Shenyang Huitian Thermal | 55 | |
| Yongdong Fan | Tianjin Realty Development | 56 | |
| Ruijun Liu | Jiangsu Xinning Modern | 47 | |
| Jie Yang | Tianjin Realty Development | 56 | |
Management Performance
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.11 |
Jafron Biomedical Leadership Team
Elected by the shareholders, the Jafron Biomedical's board of directors comprises two types of representatives: Jafron Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jafron. The board's role is to monitor Jafron Biomedical's management team and ensure that shareholders' interests are well served. Jafron Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jafron Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaolian He, Chief Officer | ||
| De Li, Deputy Manager | ||
| Xueyun Liao, Financial Controller | ||
| Cong Huang, Board Secretary | ||
| Xian Tang, Deputy Director | ||
| Fan Dong, GM Directors | ||
| Guang Zhang, Deputy Director | ||
| Aijun Wu, Deputy Manager | ||
| Kui Jin, Deputy Mang | ||
| Kai Zeng, Deputy Director | ||
| Rui Wang, General Manager |
Jafron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jafron Biomedical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.31 % | ||||
| Operating Margin | 0.42 % | ||||
| Current Valuation | 23.25 B | ||||
| Shares Outstanding | 798.6 M | ||||
| Shares Owned By Insiders | 51.06 % | ||||
| Shares Owned By Institutions | 13.16 % | ||||
| Price To Book | 7.40 X | ||||
| Price To Sales | 9.25 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Jafron Stock
Jafron Biomedical financial ratios help investors to determine whether Jafron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jafron with respect to the benefits of owning Jafron Biomedical security.